We are very proud to share the results obtained on the reduction of our carbon footprint! Once again, at Moehs Group, we continue striving and working hard to fulfil our commitment to respect the environment. In this last calculation of 2023, carried out by Cecot, we have achieved lower emissions compared to the previous period, […]

On Sunday 7th April Oxfam Intermón organized the TRAILWALKER walk, the biggest sporting and solidarity challenge that consists of covering 100 km in 32 hours, 55 km in 16 hours, or 10 km in 4 hours. The goal? To turn each participant’s kilometres into water. With the donations, they respond to the poverty caused by

Moehs Group participates in the S3 Indústria project together with teachers from the Chemistry department of the Institutes Federica Montseny (Burjassot, Valencia) and Dr. Peset Aleixandre (Paterna, Valencia). With this project, thanks to the #ConvocatoriaDualiza of CaixaBank, it aims to generate new learning situations on the subject of air pollution. The first day of the

We are proud to announce that the Moehs Research and Development project regarding nitroso-Sitagliptin impurity has been published by the scientific Journal of Separation Science Plus. This a very important step if we take into consideration that this impurity is classified as a potentially genotoxic impurity. The pharma industry is still facing the nitrosamines nightmare.

Moehs Group participated in CPHI Barcelona, the great European event of the pharmaceutical sector. At our stand 6B40 in Hall 6, our team received hundreds of visitors interested in our services and shared space with other professionals of the sector. Thanks to all the organization for this magnificent event.  

Moehs Group has just received Japanese patent JP7327736 for the API Edoxaban. This document is related to an improving method to produce EDOXABAN allowing us to strengthen our position as an API manufacturer worldwide.

We are proud to announce that Moehs has taken one step further on the nitrosamines project by publishing an article in the scientific Journal of Separation Science. This is a very important step in the race to have better control of the nitrosamine drug substance-related impurities, NDSRIs in the APIs. At Moehs we have developed

We announce the appointment of Mr. Javier del Rio as its new CEO replacing Mr. Francisco Escribano after a long career within Moehs. Mr. del Rio is a pharmacist with extensive experience in the pharmaceutical industry, having held various leadership positions in companies of the sector. His background and knowledge will be key to lead

We end this special week, full of Christmas festivities, with our last video commemorating Moehs’ 60th anniversary. Thank you all for making it possible!

We thank our entire team of professionals for your involvement in the Moehs Group’s 60th anniversary tribute. Thank you for your words, we love to see how we continue growing together!